Delivery Order SPE2DB24D3014-SPE2DB25FKUSW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Brilinta 90 mg tablets (60-count packaging) with a ceiling value of $7,397.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $2,057.86. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion on September 17, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,775.51 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) on September 5, 2025, with completion expected by September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $1,046.51. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement mechanism. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,329.04. This non-set-aside delivery order represents the continuation of pharmaceutical supply services to support federal medical procurement needs, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Brilinta 90 mg tablets (60-count units) valued at $3,168.70 under a firm fixed price contract. This delivery order was competitively awarded without set-aside designation and is set to be completed by August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.04 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Brilinta 60 mg tablets (quantity 60 count) valued at $1,664.52. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is due for completion by September 16, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUSWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) valued at $3,581.91. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by September 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a broad spectrum of pharmaceutical products, including brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. The Brilinta supply supports the Defense Logistics Agency's medical supply chain requirements for cardiovascular treatment medications used throughout military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/18/25 |